Literature DB >> 2600291

Fluid requirements of patients with burns and inhalation injuries in an intensive care unit.

K R Hughes1, R F Armstrong, M D Brough, N Parkhouse.   

Abstract

We have studied 9 patients with burns (20%-75%) who had inhalation injuries and compared their actual fluid requirements with their requirements calculated from the Muir and Barclay formula. All patients were resuscitated with plasma protein fraction at a rate sufficient to keep their physiological variables within the following range: heart rate less than 120/min, central venous pressure 8-12 cm H2O, urine output greater than 30-50 ml/h, systolic blood pressure greater than 90 mm Hg and diastolic blood pressure greater than 60 mm Hg. The amount of plasma protein fraction needed was 4.38 +/- 1.26 ml/kg/% burn in the first 24 h and 2.15 +/- 0.97 ml/kg/% burn in the second 24 h. This is an increase of 75% and 110% respectively above values predicted from the formula. We suggest that the observed difference is due to a combination of the presence of an inhalation injury which increases fluid requirements by approximately 30% in the first 24 h and the use of plasma protein fraction rather than the dried plasma used in the original Muir and Barclay formula.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2600291     DOI: 10.1007/bf00255603

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  14 in total

Review 1.  Fluid resuscitation of the thermally injured patient. Current concepts with definition of clinical subsets and their specialized treatment.

Authors:  W D Rubin; M M Mani; J M Hiebert
Journal:  Clin Plast Surg       Date:  1986-01       Impact factor: 2.017

2.  Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury.

Authors:  C W Goodwin; J Dorethy; V Lam; B A Pruitt
Journal:  Ann Surg       Date:  1983-05       Impact factor: 12.969

3.  Individualized fluid resuscitation based on haemodynamic monitoring in the management of extensive burns.

Authors:  N Aikawa; K Ishibiki; C Naito; O Abe; S Yamamoto; M Motegi; M Sudo
Journal:  Burns Incl Therm Inj       Date:  1982-03

4.  The effect of resuscitation on inhalation injury.

Authors:  D N Herndon; D L Traber; L D Traber
Journal:  Surgery       Date:  1986-08       Impact factor: 3.982

5.  Pulmonary vascular permeability to transferrin in the pulmonary oedema of renal failure.

Authors:  G M Rocker; A G Morgan; D Pearson; G S Basran; D J Shale
Journal:  Thorax       Date:  1987-08       Impact factor: 9.139

6.  Prophylactic intubation and continuous positive airway pressure in the management of inhalation injury in burn victims.

Authors:  B Venus; T Matsuda; J B Copiozo; M Mathru
Journal:  Crit Care Med       Date:  1981-07       Impact factor: 7.598

7.  Inhalation injury in burned patients: effects and treatment.

Authors:  D N Herndon; R E Barrow; H A Linares; R L Rutan; T Prien; L D Traber; D L Traber
Journal:  Burns Incl Therm Inj       Date:  1988-10

8.  Causes of mortality in patients with the adult respiratory distress syndrome.

Authors:  A B Montgomery; M A Stager; C J Carrico; L D Hudson
Journal:  Am Rev Respir Dis       Date:  1985-09

9.  The use of the Mount Vernon formula in the treatment of burn shock.

Authors:  I Muir
Journal:  Intensive Care Med       Date:  1981-01       Impact factor: 17.440

10.  Effect of inhalation injury on fluid resuscitation requirements after thermal injury.

Authors:  P D Navar; J R Saffle; G D Warden
Journal:  Am J Surg       Date:  1985-12       Impact factor: 2.565

View more
  2 in total

1.  Cardiovascular dysfunction in burns: review of the literature.

Authors:  G S Abu-Sittah; K A Sarhane; S A Dibo; A Ibrahim
Journal:  Ann Burns Fire Disasters       Date:  2012-03-31

2.  Burn mortality in patients with preexisting cardiovascular disease.

Authors:  Laquanda Knowlin; Trista Reid; Felicia Williams; Bruce Cairns; Anthony Charles
Journal:  Burns       Date:  2017-02-08       Impact factor: 2.744

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.